Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
July 25, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for March 16, 2008 Subscribe to this News Feed      
 

New York City Dentist Takes Stand Against Oral Cancer

Dr. Jan Linhart employs new technology to detect precancerous and early stage cancerous lesions.

New York, NY (PRWEB) March 16, 2008 -- Dr. Linhart now offers oral cancer screenings using the VELscope® with every cleaning, and thus is helping to prevent this dangerous and potentially deadly disease.

ANews Imagepproximately 35,000 new cases of oral cancer are diagnosed each year, and of those patients more than 50 percent will die within five years. In addition, oral cancer is more prevalent than cervical cancer and melanoma, which should put it in the forefront of people's minds. Dr. Linhart emphasizes that, "Up until now, the only reliable, affordable oral cancer screening has been visual examination during hygiene appointments, yet new technology has changed this."

Up until now, the only reliable, affordable oral cancer screening has been visual examination during hygiene appointments, yet new technology has changed this.
The VELscope® is a revolutionary device that allows Dr. Linhart and his team to detect tissue changes in the oral cavity before they become apparent to the naked eye.

Produced by LED Medical Diagnostics Inc. (LED-MD), the VELscope® uses tissue fluorescence that can be directly viewed by Dr. Linhart. This fluorescence varies by tissue condition, and thus allows for visualization of unhealthy tissue; it allows the doctor to actually see precancerous lesions and early stage oral cancers. As with any cancer, early detection is essential in long-term prognosis and treatment.

The VELscope® is the only device cleared by the FDA and Health Canada to help detect oral mucosal lesions that might not be apparent or visible to the naked eye. Abnormal tissue typically appears as an irregular, dark green or black area that stands out against the otherwise normal, green fluorescence of healthy oral tissue.

Dr. Jan Linhart, DDS, is a restorative dentist in Manhattan who is taking innovative action to help prevent oral cancer in his patients. For over 25 years, Dr. Linhart has been improving his patient's oral health, and now with advancements in modern technology, he is able to provide early detection of oral cancer, one of the most dangerous oral diseases.

Step into our office to inquire about VELscope® preventative oral cancer detection screenings and many other state-of-the-art dental services that we offer, including porcelain veneers, dental implants, laser whitening, and more.

###

Post Comment:
Trackback URL: http://ca.prweb.com/pingpr.php/WmV0YS1IYWxmLVN1bW0tSG9yci1Ib3JyLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


Other Releases by this Member
OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
Ellen S. Linhart, Chief Marketing Office
212-682-5180
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright